The relationship between iron levels and insulin sensitivity has long been recognized and studied in humans and other animals, but largely ignored in the equine population, including in horses with equine metabolic syndrome (EMS). With the knowledge that elevated circulating insulin is the direct and most common cause of laminitis associated with equine metabolic disorders, the association between equine insulin and iron dysregulation needs further investigation.
Eleanor Kellon, VMD, and Kathleen Gustafson, PhD, of the Equine Cushing’s and Insulin Resistance Group (ECIR) performed a retrospective analysis of lab results maintained in the group’s database and data from the only controlled feeding study in horses. The ECIR Group is the largest field-trial database for Pituitary Pars Intermedia Dysfunction (PPID) and EMS in the world and provides the latest research, diagnosis, and treatment information, in addition to dietary recommendations for horses with these conditions.
The latter study was specifically designed to substitute horses as a model for captive black rhinos, a cousin of the horse, because the researchers recognized the relationship between metabolic disease and iron overload in rhinos.
All animals from the ECIR database had abnormally elevated insulin (hyperinsulinemia). Ferritin, a measure of body iron stores, also exceeded the published reference range in all animals, and there was a tendency for iron levels to increase with age. Likewise, data from the previously published report showed that ferritin was significantly elevated in the group with confirmed hyperinsulinemia when compared to the group with a normal insulin response.
Kellon and Gustafson suggest that these results indicate possible similar interactions between hyperinsulinemia and body iron burden in the horse and that iron may be a modifiable risk factor for hyperinsulinemia. They emphasize that iron is unlikely to be a primary causal factor, but that the interaction is worth scientific investigation in controlled studies. Studies investigating the bidirectional relationship between iron and hyperinsulinemia in horses are extraordinarily limited, despite considerable scientific inquiry in other species. The goal should be to increase awareness of the potential for iron overload in horses with hyperinsulinemia and stimulate further study.
The full study, “Possible Dysmetabolic Hyperferritinemia in Hyperinsulinemic Horses,” can be found online.
The mission of the ECIR Group Inc. is to improve the welfare of equines with metabolic disorders via a unique interface between basic research and real-life clinical experience. Prevention of laminitis is the ultimate goal. The ECIR Group serves the scientific community, practicing clinicians, and owners by focusing on investigations most likely to quickly, immediately, and significantly benefit the welfare of the horse.
For more information, please visit www.ecirhorse.org.
Flopping ears bounce with every step down the trail as a string of six mules begin the trek from the…
Speaking on a stage surrounded by the glitz and glamour of the Miss America Pageant, Sabrina Lewis stands out with…
Insurance. It’s a fact of life for most adults. We insure our vehicles, homes, businesses—even our smartphones. We buy life…
Stay up to date on the action from the 2025 Defender Kentucky Three-Day Event. Find information about the event, including…
Lexington, Ky. — This year’s Cosequin® Lexington 4*-S will serve as a US Equestrian Open Eventing Series Qualifier when the…
Much like the cream center of an Oreo cookie, there is a sweet spot in the middle of Ocala winter…